Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2002 15
2003 6
2004 13
2005 10
2006 14
2007 18
2008 12
2009 13
2010 14
2011 7
2012 17
2013 19
2014 25
2015 22
2016 22
2017 9
2018 8
2019 1
2020 2
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Thompson AJ, et al. Among authors: miller dh. Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275977 Review.
Optic neuritis.
Toosy AT, Mason DF, Miller DH. Toosy AT, et al. Among authors: miller dh. Lancet Neurol. 2014 Jan;13(1):83-99. doi: 10.1016/S1474-4422(13)70259-X. Lancet Neurol. 2014. PMID: 24331795 Review.
Diagnosis of multiple sclerosis: progress and challenges.
Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Brownlee WJ, et al. Among authors: miller dh. Lancet. 2017 Apr 1;389(10076):1336-1346. doi: 10.1016/S0140-6736(16)30959-X. Epub 2016 Nov 24. Lancet. 2017. PMID: 27889190 Review.
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F. Montalban X, et al. Among authors: miller dh. Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20. Mult Scler. 2018. PMID: 29353550
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Polman CH, et al. Among authors: miller dh. N Engl J Med. 2006 Mar 2;354(9):899-910. doi: 10.1056/NEJMoa044397. N Engl J Med. 2006. PMID: 16510744 Free article. Clinical Trial.
Baló's concentric sclerosis.
Hardy TA, Miller DH. Hardy TA, et al. Among authors: miller dh. Lancet Neurol. 2014 Jul;13(7):740-6. doi: 10.1016/S1474-4422(14)70052-3. Lancet Neurol. 2014. PMID: 24943346 Review.
Clinically isolated syndromes.
Miller DH, Chard DT, Ciccarelli O. Miller DH, et al. Lancet Neurol. 2012 Feb;11(2):157-69. doi: 10.1016/S1474-4422(11)70274-5. Lancet Neurol. 2012. PMID: 22265211 Review.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators. Lublin F, et al. Among authors: miller dh. Lancet. 2016 Mar 12;387(10023):1075-1084. doi: 10.1016/S0140-6736(15)01314-8. Epub 2016 Jan 28. Lancet. 2016. PMID: 26827074 Free article. Clinical Trial.
Primary-progressive multiple sclerosis.
Miller DH, Leary SM. Miller DH, et al. Lancet Neurol. 2007 Oct;6(10):903-12. doi: 10.1016/S1474-4422(07)70243-0. Lancet Neurol. 2007. PMID: 17884680 Review.
Natalizumab therapy for multiple sclerosis.
Chataway J, Miller DH. Chataway J, et al. Among authors: miller dh. Neurotherapeutics. 2013 Jan;10(1):19-28. doi: 10.1007/s13311-012-0171-4. Neurotherapeutics. 2013. PMID: 23307290 Free PMC article. Review.
216 results